Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson, developed Invokana to treat Type 2 diabetes. Invokana is a sodium-glucose co-transporter 2 (SGLT2) inhibitor designed to help control blood sugar levels [...]
Good nutrition combined with physical activity are an important part of leading a healthy lifestyle. Your diet can help you to reach and maintain a healthy weight, reduce your risk [...]
GOOGLE UPDATED ITS ALGORITHM AGAIN – WHY DO I CARE? Many of us have heard about Google updating, but may not be sure what that means or if it even [...]
FOLLOW THE LEAD GENERATION LEADER All businesses need clients to prosper, but how do they find these clients? Through a lead generation and lead procurement system. And, most importantly, measuring [...]
In a Philadelphia court, Johnson & Johnson (J&J) just paid out its largest award yet, $70 million for their prescription drug Risperdal (Risperidone). Criminal charges are tied to allegations that [...]
Persist software only requires two staff members to take incoming calls, generated from our intelligent call center software. In one day, 628 phone calls are made, with 221 voice mails [...]
2015 is out and 2016 is in...does your firm have what it takes to make 2016 the best year of your law practice? Most of us are reflecting on what [...]
Friday, December 4, the FDA announced that its concerns about SGLT2 inhibitors were confirmed. FDA Concludes Invokana, SGLT2 Inhibitors, Pose Serious Risks. In May 2015, the FDA announced it was investigating [...]
If you want to position yourself optimally for success with mass torts, you need to diversify. How do we do that? One of the best ways to diversify is to [...]
Before claims ever become part of a mass tort, they often start as a hunch. Perhaps an FDA recall is released, a new study comes out on risks of a [...]
